Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.
Also called NCT03951207
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 259 participants
- Sponsor
- Registry
-
NCT03951207
-
- Other papers using this trial's data
- Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03951207. Randomized; no masking; primary purpose treatment. Start 2019-05-30 (actual); primary completion 2021-09-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
- Acronym
- CORONA
- Condition
- Dyslipidemias
- Condition
- Hypertension
- Intervention (Drug)
- Rosuampin 10/5mg
- Intervention (Drug)
- Rosuampin 20/5mg
- Intervention (Drug)
- Amlodipine/Atorvastatin 5/20mg
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct03951207- Content hash
9ec9df8a967095861cbc9209babdc8f83b2e2ed551d50f25d4e755aede143dc5